Cargando…
Intranasal delivery of full-length anti-Nogo-A antibody: A potential alternative route for therapeutic antibodies to central nervous system targets
Antibody delivery to the CNS remains a huge hurdle for the clinical application of antibodies targeting a CNS antigen. The blood–brain barrier and blood–CSF barrier restrict access of therapeutic antibodies to their CNS targets in a major way. The very high amounts of therapeutic antibodies that are...
Autores principales: | Correa, Daphne, Scheuber, Myriam I., Shan, Huimin, Weinmann, Oliver W., Baumgartner, Yves A., Harten, Aliona, Wahl, Anna-Sophia, Skaar, Kirstin L., Schwab, Martin E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942809/ https://www.ncbi.nlm.nih.gov/pubmed/36649432 http://dx.doi.org/10.1073/pnas.2200057120 |
Ejemplares similares
-
Targeting Therapeutic Antibodies to the CNS: a Comparative Study of Intrathecal, Intravenous, and Subcutaneous Anti-Nogo A Antibody Treatment after Stroke in Rats
por: Wahl, Anna-Sophia, et al.
Publicado: (2020) -
Anti-NOGO Antibody Neuroprotection in a Rat Model of NAION
por: Johnson, Mary A., et al.
Publicado: (2021) -
Anti-Nogo-A antibodies prevent vascular leakage and act as pro-angiogenic factors following stroke
por: Rust, Ruslan, et al.
Publicado: (2019) -
Exercise-induced Nogo-A influences rodent motor learning in a time-dependent manner
por: Stehle, Jörg H., et al.
Publicado: (2021) -
Nogo-A expressed in Schwann cells impairs axonal regeneration after peripheral nerve injury
por: Pot, Caroline, et al.
Publicado: (2002)